Sirolimus-Coated Balloon in Femoropopliteal Steno-Occlusive Disease: Efficacy, Safety, and 1-Year Outcomes. An All-Comers Registry.
Michele FranzeseArmando PucciarelliFrancesco SpioneLuigi SalemmeGrigore PopusoiMarco FerroneGiuseppe Di GioiaEnrico Rathina RajSebastiano VerdolivaEugenio StabileTullio TesorioAngelo CioppaPublished in: Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists (2023)
In femoropopliteal steno-occlusive lesions paclitaxel drug-coated devices have been proved to be able to achieve a better vessel patency during follow-up compared with uncoated balloon, but according to a recent meta-analysis they may carry an elevated risk of late mortality. Sirolimus results in a wider therapeutic range with a 3-fold higher margin of safety. Sirolimus coated devices have recently been proposed as an alternative. This study suggests that using a novel sirolimus-coated balloon is a safe and effective treatment option for femoropopliteal steno-occlusive lesions.